Professor Amanj Kurdi

Strathclyde Institute of Pharmacy and Biomedical Sciences

Contact

Personal statement

Professor Kurdi is a Professor of Pharmacoepidemiology and Pharmacy Practice. He specialises in Pharmacoepidemiology and Drug Utilisation Research, especially concerning cardiovascular diseases, diabetes, and antibiotics. This includes studying medication adherence and persistence through the analysis of secondary databases and patient-level data, utilising a range of statistical and analytical methods.

Additionally, Professor Kurdi is keen on exploring Health Service Research and the evaluation of health policies and clinical guidelines' effects. Open to both national and international collaborations with fellow researchers and academics, Dr. Kurdi actively participates in events and conferences like EuroDURG and ICPE, fostering a collaborative environment for advancing research in these areas.

Back to staff profile

Publications

Impact of gabapentinoids’ reclassification policy and COVID-19 on gabapentinoids’ utilization pattern and their associated mortality in Scotland and Northern Ireland : a segmental regression analysis
Alrahmani Abdullah, Azeez Mabast, Baker Sahar, Kurdi Amanj
Expert Review of Clinical Pharmacology (2025)
https://doi.org/10.1080/17512433.2025.2587174
Challenges regarding the provision of antibiotics via the informal sector across low- and middle-income countries and potential ways forward
Maluleke Tiyani Milta, Rehman Inaam Ur, Kurdi Amanj, Godman Brian, Meyer Johanna C
Journal of the Medical College for Women and Hospital (2025)
A comprehensive systematic review of types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class
Madanat Faisal, Noorsaeed Solafa, Alkhlaifat Rahaf Ghaleb Suleiman, Mueller Tanja, Kurdi Amanj
Expert Review of Clinical Pharmacology (2025)
https://doi.org/10.1080/17512433.2025.2585449
Knowledge gaps influencing inappropriate surgical antibiotic prophylaxis prescribing in Kuwait : qualitative study
Alshatti Fahad A H M S, Boyter Anne, Kurdi Amanj
Research in Social and Administrative Pharmacy Vol 21, pp. e62 (2025)
https://doi.org/10.1016/j.sapharm.2025.06.068
Effectiveness of deprescribing tools and interventions in detecting and deprescribing potentially inappropriate medications and their effect on patients' clinical outcomes : a systematic review
Madanat Faisal, Noorsaeed Solafa, Alkhlaifat Rahaf, Mueller Tanja, Kurdi Amanj
Research in Social and Administrative Pharmacy Vol 21, pp. e63 (2025)
https://doi.org/10.1016/j.sapharm.2025.06.072
Utilisation trends of lipid lowering therapies between 2017 and 2022 and lipid target attainment among patients receiving proprotein convertase subtilisin-kexin type 9 inhibitors at a specialised tertiary hospital
Alsaffar Noor Ahmed Jassim, Bennie Marion, Kurdi Amanj, Alowayesh Maryam
Research in Social and Administrative Pharmacy Vol 21, pp. e60 (2025)
https://doi.org/10.1016/j.sapharm.2025.06.061

More publications

Back to staff profile

Professional Activities

Invited Guest Speaker at the 15th International Congress of Pharmaceutical Sciences (CIFARP 2025)around Real-world evidence
Speaker
29/10/2025
CPD course: Alkitab university pharmacy students summer school
Organiser
7/7/2025
NORDIC Social Pharmacy Conference 2025
Organiser
4/6/2025
External Examiner for the “Professional Certificate in Pharmacoepidemiology & Pharmacovigilance” course at London School of Hygiene and Tropical Medicine
Examiner
24/2/2025
Iraqi Journal of Pharmacy (Journal)
Peer reviewer
13/8/2024
Positioning Pharmacists in advancing Primary Health Care
Speaker
13/6/2024

More professional activities

Projects

Tackling antimicrobial resistance in Saudi Arabia: a multidisciplinary program to instigating evidence-based, theory-driven antimicrobial stewardship interventions using mixed-method approach
Elrggal, Mahmoud (CoPI) Kurdi, Amanj (Principal Investigator)
A 48 months project funded by The Saudi Basic Science Initiative, Research Development and Innovation Authority (RDIA), ~£300K
01-Jan-2025 - 30-Jan-2029
Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies
Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
01-Jan-2024 - 30-Jan-2025
Cancer Medicines Outcomes Programme - Public Health Scotland
Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
01-Jan-2024 - 31-Jan-2027
Prescribing medicines use in pregnancy: A scoping review protocol
Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
10-Jan-2024 - 14-Jan-2024
Profiling and assessing medicines use in pregnancy in Scotland: a population-based, whole system prescribing approach using routine data from clinical care
Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Co-investigator)
01-Jan-2023 - 30-Jan-2027
PHS Medicines Programme
Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)
01-Jan-2023 - 30-Jan-2028

More projects

Back to staff profile

Contact

Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences

Email: amanj.baker@strath.ac.uk
Tel: 548 2181